194 related articles for article (PubMed ID: 20064475)
1. Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras.
Ellingson JS; Wang Y; Layton S; Ciacci-Zanella J; Roof MB; Faaberg KS
Vaccine; 2010 Mar; 28(14):2679-86. PubMed ID: 20064475
[TBL] [Abstract][Full Text] [Related]
2. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of porcine reproductive and respiratory syndrome virus strain MN184 using chimeric construction with vaccine sequence.
Wang Y; Liang Y; Han J; Burkhart KM; Vaughn EM; Roof MB; Faaberg KS
Virology; 2008 Feb; 371(2):418-29. PubMed ID: 17976680
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
5. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate.
Cano JP; Dee SA; Murtaugh MP; Pijoan C
Vaccine; 2007 May; 25(22):4382-91. PubMed ID: 17451850
[TBL] [Abstract][Full Text] [Related]
6. Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates.
Welch SK; Jolie R; Pearce DS; Koertje WD; Fuog E; Shields SL; Yoo D; Calvert JG
Vet Immunol Immunopathol; 2004 Dec; 102(3):277-90. PubMed ID: 15507311
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
[TBL] [Abstract][Full Text] [Related]
8. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
[TBL] [Abstract][Full Text] [Related]
9. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred.
Prieto C; Alvarez E; MartÃnez-Lobo FJ; Simarro I; Castro JM
Vet J; 2008 Mar; 175(3):356-63. PubMed ID: 17560818
[TBL] [Abstract][Full Text] [Related]
10. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18.
Shen G; Jin N; Ma M; Jin K; Zheng M; Zhuang T; Lu H; Zhu G; Jin H; Jin M; Huo X; Qin X; Yin R; Li C; Li H; Li Y; Han Z; Chen Y; Jin M
Vaccine; 2007 May; 25(21):4193-202. PubMed ID: 17418456
[TBL] [Abstract][Full Text] [Related]
11. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
[TBL] [Abstract][Full Text] [Related]
12. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions.
Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL
J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.
Jiang Y; Xiao S; Fang L; Yu X; Song Y; Niu C; Chen H
Vaccine; 2006 Apr; 24(15):2869-79. PubMed ID: 16446016
[TBL] [Abstract][Full Text] [Related]
14. Development of a porcine reproductive and respiratory syndrome virus differentiable (DIVA) strain through deletion of specific immunodominant epitopes.
de Lima M; Kwon B; Ansari IH; Pattnaik AK; Flores EF; Osorio FA
Vaccine; 2008 Jul; 26(29-30):3594-600. PubMed ID: 18538899
[TBL] [Abstract][Full Text] [Related]
15. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
Fontanella E; Ma Z; Zhang Y; de Castro AM; Shen H; Halbur PG; Opriessnig T
Vaccine; 2017 Jan; 35(1):125-131. PubMed ID: 27876202
[TBL] [Abstract][Full Text] [Related]
16. Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV.
Opriessnig T; Halbur PG; Yoon KJ; Pogranichniy RM; Harmon KM; Evans R; Key KF; Pallares FJ; Thomas P; Meng XJ
J Virol; 2002 Dec; 76(23):11837-44. PubMed ID: 12414926
[TBL] [Abstract][Full Text] [Related]
17. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.
Labarque G; Reeth KV; Nauwynck H; Drexler C; Van Gucht S; Pensaert M
Vaccine; 2004 Oct; 22(31-32):4183-90. PubMed ID: 15474708
[TBL] [Abstract][Full Text] [Related]
18. Genomic sequence and virulence comparison of four Type 2 porcine reproductive and respiratory syndrome virus strains.
Brockmeier SL; Loving CL; Vorwald AC; Kehrli ME; Baker RB; Nicholson TL; Lager KM; Miller LC; Faaberg KS
Virus Res; 2012 Oct; 169(1):212-21. PubMed ID: 23073232
[TBL] [Abstract][Full Text] [Related]
19. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV.
Scortti M; Prieto C; Alvarez E; Simarro I; Castro JM
Vet Rec; 2007 Dec; 161(24):809-13. PubMed ID: 18083979
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
